Epidiolex CBD Epilepsy Drug Receives Approval in Europe
WeedAdvisor
SEPTEMBER 24, 2019
On June 25, 2018, the U.S. GW Pharmaceuticals created the medication after studies showed surprising success treating severe childhood epilepsy, specifically Lennox-Gastaut Syndrome and Dravet Syndrome. The post Epidiolex CBD Epilepsy Drug Receives Approval in Europe appeared first on WeedAdvisor. In the U.S.,
Let's personalize your content